This page shows the latest Alzheimer's Society news and features for those working in and with pharma, biotech and healthcare.
A new look at pivotal trial data described as hard-to-interpret. A much-anticipated presentation of data from Biogen’s pivotal trials programme for Alzheimer’s disease candidate aducanumab has ... Dr James Pickett, head of research at Alzheimer’s
The project is being co-led by the Oxford Health NHS Foundation Trust and the Alzheimer’s Society and they’ll assess an online programme called ‘ Caring for Me and You’. ... Dr Doug Brown, director of research and development at the Alzheimer’s
in a model of Alzheimer's disease (AD) by preventing the production of neurotoxic beta-amyloid aggregates. ... A note of caution has been sounded by Doug Brown, R&D director at the Alzheimer's Society, who noted that Bexarotene has many side effects
Clinical trials have provided some preliminary evidence that drugs targeting amyloid may help delay Alzheimer's disease (AD), although scientists stress it is far too early to draw conclusions. ... The trial still has another two years to run. The
The funding will focus on neurodegenerative conditions, such as dementia, motor neurone disease and Parkinson's disease for which there is an unmet need. ... Neuro–MAP's partners are Alzheimer's Association US, Alzheimer Research UK, Alzheimer's
Organisations signed up to the TIS include charities, such as the Alzheimer's Society and the British Liver trust, private healthcare provider Bupa and many NHS trusts, but Boehringer is the ... And to do so, it's vital that all parties have the right
More from news
Approximately 1 fully matching, plus 29 partially matching documents found.
Georgina Carr, Head of External Relations and Campaigns at the MS Society, works with people with MS on a daily basis: “Co-creation has been key in the health charity sector ... Dr Doug Brown, Chief Policy and Research Officer at Alzheimer’s Society,
750 people with prodromal to mild Alzheimer’s; that too is scheduled to complete in 2020. ... The project is a joint £250m investment into dementia research led by the Medical Research Council, alongside the Alzheimer’s Society and Alzheimer’s
The role is the first position at the company that Dugi has taken outside Boehringer's homeland. ... In signing up to The Information Standard, Boehringer joins the likes of the Alzheimer's Society and the British Liver Trust, private healthcare provider
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics
During this time, he has worked closely with local authorities to publish the Merton Mental Health Needs Assessment and helped to develop the Alzheimer's Society's Dementia Hub. ... capability. “Following Laurence's appointment, we can now offer
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Alzheimer’s Research UK. Alzheimer’s Society. Basic Needs. Biogen. Butterfly Scheme. Cardiomyopathy UK. ... Marketing Design Awards. New York Festivals. PM Society Advertising Awards. PM Society Digital Awards.
A total of 24 charities were put forward and vigorously defended, including Crisis, Alzheimer’s Society, Stroke Association, War Child, Orangutan Foundation, Age UK, Solar Aid, and Battersea Dogs and Cats ... Adam Boucher, emotive’s Client Services
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...